← Back to Search

Floatation Therapy for Anorexia

N/A

Waitlist Available

Led By Sahib Khalsa, MD, PhD

Research Sponsored by Laureate Institute for Brain Research, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Primary clinical diagnosis of anorexia nervosa

Receiving inpatient treatment for eating disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will study the effects of Floatation-REST on symptoms of anorexia nervosa.

Who is the study for?

This trial is for individuals with anorexia nervosa who are currently in inpatient treatment, can walk on their own, haven't started new meds recently, and can lay flat without discomfort. They must have a BMI of at least 16 and be able to use a smartphone with internet. People with severe depression, self-harm behaviors, certain blood pressure issues or psychotic disorders cannot join.Check my eligibility

What is being tested?

The study is examining the impact of Floatation-REST therapy combined with usual care versus usual care alone on anorexia nervosa symptoms. Participants will either continue their regular treatment or receive additional sessions of Floatation-REST where they'll experience reduced environmental stimulation.See study design

What are the potential side effects?

While not explicitly stated here, potential side effects from Floatation-REST may include dizziness or nausea due to the sensory deprivation environment; however, these are generally mild and temporary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My condition is diagnosed as anorexia nervosa.

Select...

I am currently hospitalized for an eating disorder treatment.

Select...

I can walk on my own without help.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body image dissatisfaction score on the Photographic Figure Rating Scale

Secondary outcome measures

Anxiety on the NIH Promis Anxiety Scale

Anxiety on the Spielberger State Trait Anxiety Inventory

Anxiety sensitivity on the Anxiety Sensitivity Index-3R

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual careExperimental Treatment1 Intervention

Participants will be assessed along the same time periods, i.e., before and after a 60 minute window, on 8 separate occasions. Ratings of the experience will be collected before and after each time period.

Group II: Floatation-RESTExperimental Treatment1 Intervention

Participants will float supine in a pool of water saturated with epsom salt, in a light and sound attenuated chamber, for up to 60 minutes, on 8 separate occasions. Ratings of the experience will be collected before and after each float.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Usual care

2011

Completed Phase 4

~23770

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Laureate Institute for Brain Research, Inc.Lead Sponsor

50 Previous Clinical Trials

5,277 Total Patients Enrolled

5 Trials studying Anorexia Nervosa

395 Patients Enrolled for Anorexia Nervosa

Sahib Khalsa, MD, PhDPrincipal InvestigatorLaureate Institute for Brain Research

3 Previous Clinical Trials

222 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently accepting participants?

"The information hosted on clinicaltrials.gov reveals that this particular medical trial is no longer looking for participants, despite its initial posting on March 16th 2018 and the most recent update occurring April 9th 2022. However, 77 other studies are currently seeking candidates at this moment in time."

Answered by AI

Am I qualified to participate in this research endeavor?

"This research project, comprising of 68 patients suffering from anorexia nervosa aged between 13 and 64 years old, has certain requirements for enrolment. Specifically, the body mass index must be more than 16; there can't have been any new medications administered in the week prior to randomisation; smartphone with a data plan is necessary; independent ambulation without orthostatic hypotension plus being able to lay flat comfortably are all required."

Answered by AI

Is there an upper age limit for enrollees in this experiment?

"The age range for eligibility in this medical trial is between the ages of 13 and 64. For those outside that range, there are 38 studies related to minors and 33 focused on individuals older than 65 respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Floatation-REST and Anorexia Nervosa

2018. "Floatation-REST and Anorexia Nervosa". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03610451.

All > Anorexia Nervosa